Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +3.00p +8.96% 36.50p 36.00p 37.00p 37.25p 33.50p 33.50p 405,635 13:22:29
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.2 -4.5 -3.7 - 44.05

Futura Medical Share Discussion Threads

Showing 15401 to 15423 of 15425 messages
Chat Pages: 617  616  615  614  613  612  611  610  609  608  607  606  Older
DateSubjectAuthorDiscuss
20/1/2018
20:28
Conspiracy theorists and fake news you just can't win. No point on trying to converse to the deaf or deluded.
j777j
20/1/2018
18:03
By the way, imminent could also easily mean another 2 months but at least something is happening in the background!
aberdeen_investor
20/1/2018
17:55
Hi MTB, I understand your frustrations but I did get in touch with our middle eastern partner. I’ve been told a roll out in the UAE is imminent. Hope this helps calm you down! I know it can be frustrating but things are happening albeit at a slower pace than what investors want.
aberdeen_investor
20/1/2018
16:22
J7 CSD500 It is not 'price sensitive' to request an explanation as to why with all these long in the tooth, so-called distribution agreements signed throughout the world, only one minor one is in operation and its performance is shrouded in secrecy. All these agreements have been used by the so called distributors to keep our world beating product off the world markets. It is a very cheap way of keeping CSD from competing with their existing inferior products. Even the distributor with the deal in operation in Saudi has not chosen to introduce CSD into its other areas - why not ? - same reason perhaps? Unfortunately it is a one-trick pony until MED gets underway. But what if Barder is taken for a fool again and we have the situation of many deals but no sales Not sure what you mean by your last para. - however the CEO is very good at closing deals the only problem is that they don't seem to have a sales element and never have. I have been a shareholder for many years and was, in the early days, as enthusiastic as you appear to be, however as the years have passed without result I have become despairing of the way the BoD have thrown away the opportunity of selling such world beating products. If I had the money spare I would purchase sufficient shares myself to get on the Board and point them in the right direction. Without something drastic being done this company will carry on in the same way and throw it all away
mikethebike4
20/1/2018
08:24
You keep asking the same questions and get the same answers as no price sensitive information will be gleened by continually harassing the Ceo.Far from being a one trick pony,the appeal of Fum is that there are 5 different products.The condom is on sale and more to follow,subject to local regulatory approvals.The first pain gel license is due for application to UK regulatory approval q1,with other licensing discussions ongoing.Med2002 is in final stages of licensing partners being signed up.The police complain a huge amount of time wasted in paperwork and by continuallly harassing the Ceo you are wasting shareholders money,when he could be closing deals.
j777j
19/1/2018
17:57
Had the following e-mail exchange with Mr Barder :- How about a press release noting the enormous interest in the product(s) in the press, TV etc., dismissing the negligable side efects and stressing the benefits when compared with Viagra etc.. Also giving an idea of the stage of development and timescale of availability. All in laymans language - not too scientific Incidentally this current fervour should do wonders for your asking price for the various possible deals ! He replied :- Your proposed press release says nothing new so would look very odd. I replied :- Although it says nothing new as you say, but it will re-enforce details of Med2002 in the publics mind and would be a very good vehicle for introducing CSD500/Blue Diamond to the market. Incidentally how is CSD500 doing in Saudi ? - we have heard nothing about our only product since its launch. Where are 'the further launches of the product expected in other countries during 2017 and beyond' as mentioned on the website Also, still no product availability in Holland/Belgium - why ? - they cannot be waiting for the 18months shelf-life as they were previously happy to sell the 12months version I cannot believe how a sales opportunity like this has been wasted - why cannot TTK make them for Europe anyway ? He replied :- MED2002 is at least two years aware from launch and will not be called MED2002 when launched. I therefore disagree that it is of value to raise awareness with the public so much in advance. The recent publicity has been very much focused on healthcare practioners and educating industry around MED2002. CSD500 is a completely different product with a different indication. As I have said previously we are in the hands of our distributors and are working on a number of launches. When we have something material to say we will say it. They can sell the 12 month product however by the time it is shipped to them by the manufacturer, shipped from their depot to retailers and then distributed and put on the shelves with the individual stores this leaves a relatively short period to sell the product. As a consequence you run the risk that a certain amount of product ends up being thrown away as it runs out of shelf live which is not commercially acceptable. With the improved shelf life this helps significantly and we are therefore working with a number of distributors on this at the moment, but it always takes time. To which I replied :- Sorry Mr Barder but initially people do not remember names of medical products all they will remember is that there is a product under 'development' which will go a long way to sorting out their lovelife - the more they are reminded of this the better for sales when it is launched. When it is established people will remember its name ! CSD500 does involve the same condition as MED2002 - that is ED. Some people will use both whether it is unadvised or not. I appreciate that 12 months shelf life could cause some problems as you mention but the Belgians/Dutch were selling them before quite happily and have now been without a saleable product for nearly a year and you haven't answered my question about TTK supplying them in europe - why isn't it ? Why no news about saudi sales. I am not asking for figures just an indication - poor, OK, good or very good ? To which he replied :- I replied in my previous email however you chose to ignore my comments I replied :- I did not ignore your comments, I was asking for clarification of Futuras position :- 1. I appreciate that 12 months shelf life could cause some problems as you mention but the Belgians/Dutch were selling them before quite happily and have now been without a saleable product for nearly a year ? 2. you haven't answered my question about TTK supplying them in europe - why isn't it - (this would get over the (supposed) 18months shelf life 'problem' ? 3. Why no news about saudi sales. I am not asking for figures just an indication - poor, OK, good or very good ? This 'guide' cannot be commercially sensitive - and might be commercially advantageous if selling is good His reply :- I (unlike a number of other CEOs) am happy to answer questions from shareholders but I have a day job to do and am not going to give a running commentary. As I have previously said in response to your question 1 & 2 - With the improved shelf life this helps significantly and we are therefore working with a number of distributors on this at the moment, but it always takes time. On your question 3 – I have no idea what you mean by poor, ok, good or very good? All I will say is that we are working with them on further orders for Saudi as well as other territories where they have the rights subject to the necessary regulatory clearance. I will leave it to you to decide whether you think that is poor, ok, good etc Well, not very impressive I am afraid - relying on stock answer excuses and/or avoiding answering the questions on Saudi, Europe etc. Despite 'all the products in the pipeline' we are still only a one distributor, one product company - very poor !
mikethebike4
19/1/2018
12:50
Could the mm's be short of shares? They keep pushing the price up as if they want to buy. Not much selling though.
wi1l
19/1/2018
12:16
Yes, can't claim the second leg up was anything to do with me! But nice to see it going the other way, but such an adjustment on low trade?? Something more to it than just a bit of buying possibly (hopefully).
wi1l
19/1/2018
12:04
It's all AI driven robots that have taken over trading these days unfortunately.
j777j
19/1/2018
11:57
Recent correction hit it's 50% Fibonacci support and could rally strongly from hereImho
j777j
19/1/2018
11:36
wi1l - could you give it a few minutes and do the same again please, it's gone quiet again.
makingmillions
19/1/2018
11:22
Wake up at the back there - just added a few along with someone else by the looks of things. Doesn't take much to get the share price going in the right direction (prob woke the mm's up too!)
wi1l
18/1/2018
21:00
ZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZ
greedfear
16/1/2018
14:08
No that wasn't me. There's generally more buying in the afternoon but I suppose the price this morning was too attractive to hold back.
wi1l
16/1/2018
11:50
somebody is keen at this level - is that you wi ?
mikethebike4
16/1/2018
09:42
Well they've dropped the price but I haven't been able to buy any either??
wi1l
14/1/2018
12:14
Many thanks and I wish they WOULD get things moving, aim pharmas always seem on the cusp of a breakthrough licencing deal which takes forever to reach fruition and then something happens to delay the process. If med2002 is as good as they say they must be spoilt for choice as to who they pair up with, even GSK/Reckitt might want a second go at it.
wi1l
14/1/2018
11:18
Lombard & Octopus have 26.8 between them - them + small shareholders could influence the make-up of the Board ! - and get things moving perhaps ?
mikethebike4
14/1/2018
11:13
It's all in the link posted alreadyhttp://www.futuramedical.co.uk/content/investors/share_statistics.aspShares not in public hands (as at 2 January 2018)In terms of the AIM Rules and insofar as it is aware, 20.63% of the Company's AIM securities are not in public hands
lbo
14/1/2018
02:06
Is there some reason why you can't read the Rule 26 disclosures? Just thought it might save you the spurious speculation.
glavey
13/1/2018
10:02
Just trying to understand who owns what! It looks as though I found my figure of 1.4M from the annual accounts and I wasn't aware that the Lambs were connected "family"( thanks for that information). Although that still only makes about 13%? Throws a different light on things if this figure was much higher at 25% ie much less shares about for general trading than I thought. Only 120M in shares at most and if 55-60% are in safe hands then to me its significant because when the volume increases,and mm's become short and the price reacts accordingly when they seek to fill the extra demand. Might be wrong but I believe we are at the start of a period where a lot of shares will be changing hands and if theres not many around the price will shoot up.
wi1l
13/1/2018
08:41
Family could also mean other members who may own 1% or 2% each and therefore below the 3 percent threshold. A few of those and you’re quickly at 25 percent
aberdeen_investor
12/1/2018
15:52
I don't have the info quick to hand, if you are looking for certainty please email Mr Barder, I did the same previously.
qruz
Chat Pages: 617  616  615  614  613  612  611  610  609  608  607  606  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20180120 21:11:20